| Filed On | Filing |
|---|---|
| 12 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 | 10-Q |
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, November 10, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2026. |
| 06 Nov 2026 |
Form 4: Krulik Douglas, CAO and Interim CFO
Gave up 3,246 shares to cover exercise price or tax ($8.6K) · Gave up 2,965 shares to cover exercise price or tax ($7.68K) · Gave up 3,246 shares to cover exercise price or tax ($4.97K) · 1 more |
| 29 Sep 2026 |
Form 4: Willard Jeffrey Allen, Director
Received 250,000 shares as a grant or award · Granted 250,000 Performance Share Units |
| 29 Sep 2026 |
Form 3: Willard Jeffrey Allen, Director
No securities owned |
| 28 Sep 2026 | S-8 |
| 28 Sep 2026 | S-8 |
| 28 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
(a) Purpose. The PetMed Express, Inc. 2024 Inducement Incentive Plan (as amended and restated, the “Plan”) has two complementary purposes: (i) to attract and retain outstanding individuals to serve as employees and (ii) to increase stock... |
| 21 Sep 2026 |
Form 4: Elkeles Tamar, Director
Received 49,923 shares as a grant or award |
| 21 Sep 2026 |
Form 3: Elkeles Tamar, Director
No securities owned |
| 21 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution |
| 17 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
THIS EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is made and entered into effective as of August 28, 2026, by and between PETMED EXPRESS, INC., a Florida corporation (“Company”), and JEFFREY ALLEN WILLARD, an individual (her... |
| 13 Aug 2026 |
Form 4: Campbell Leslie C.g., Director
Received 60,000 shares as a grant or award |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
8-K: Results of Operations and Financial Condition
Delray Beach, Florida, August 13, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026. |
| 12 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
1 4917-9263-2247.3 PETMED EXPRESS, INC. 2024 OMNIBUS INCENTIVE PLAN (As amended on August 11, 2026) 1. Purpose; Effective Date and Amendment; Effect on Prior Plans. Purpose. The PetMed Express, Inc. 2024 Omnibus Incentive Plan (the “Plan... |
| 12 Aug 2026 |
Form 4: LaCamp James, Director
Received 55,555 shares as a grant or award |
| 12 Aug 2026 |
Form 4: Batushansky Peter, Director
Received 55,555 shares as a grant or award |
Loading...